457 related articles for article (PubMed ID: 18437204)
21. Risk-association of five SNPs in TOX3/LOC643714 with breast cancer in southern China.
He X; Yao G; Li F; Li M; Yang X
Int J Mol Sci; 2014 Jan; 15(2):2130-41. PubMed ID: 24481062
[TBL] [Abstract][Full Text] [Related]
22. Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women.
Rebbeck TR; DeMichele A; Tran TV; Panossian S; Bunin GR; Troxel AB; Strom BL
Carcinogenesis; 2009 Feb; 30(2):269-74. PubMed ID: 19028704
[TBL] [Abstract][Full Text] [Related]
23. Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Antoniou AC; Spurdle AB; Sinilnikova OM; Healey S; Pooley KA; Schmutzler RK; Versmold B; Engel C; Meindl A; Arnold N; Hofmann W; Sutter C; Niederacher D; Deissler H; Caldes T; Kämpjärvi K; Nevanlinna H; Simard J; Beesley J; Chen X; ; Neuhausen SL; Rebbeck TR; Wagner T; Lynch HT; Isaacs C; Weitzel J; Ganz PA; Daly MB; Tomlinson G; Olopade OI; Blum JL; Couch FJ; Peterlongo P; Manoukian S; Barile M; Radice P; Szabo CI; Pereira LH; Greene MH; Rennert G; Lejbkowicz F; Barnett-Griness O; Andrulis IL; Ozcelik H; ; Gerdes AM; Caligo MA; Laitman Y; Kaufman B; Milgrom R; Friedman E; ; Domchek SM; Nathanson KL; Osorio A; Llort G; Milne RL; Benítez J; Hamann U; Hogervorst FB; Manders P; Ligtenberg MJ; van den Ouweland AM; ; Peock S; Cook M; Platte R; Evans DG; Eeles R; Pichert G; Chu C; Eccles D; Davidson R; Douglas F; ; Godwin AK; Barjhoux L; Mazoyer S; Sobol H; Bourdon V; Eisinger F; Chompret A; Capoulade C; Bressac-de Paillerets B; Lenoir GM; Gauthier-Villars M; Houdayer C; Stoppa-Lyonnet D; ; Chenevix-Trench G; Easton DF;
Am J Hum Genet; 2008 Apr; 82(4):937-48. PubMed ID: 18355772
[TBL] [Abstract][Full Text] [Related]
24. Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium.
Figueroa JD; Garcia-Closas M; Humphreys M; Platte R; Hopper JL; Southey MC; Apicella C; Hammet F; Schmidt MK; Broeks A; Tollenaar RA; Van't Veer LJ; Fasching PA; Beckmann MW; Ekici AB; Strick R; Peto J; dos Santos Silva I; Fletcher O; Johnson N; Sawyer E; Tomlinson I; Kerin M; Burwinkel B; Marme F; Schneeweiss A; Sohn C; Bojesen S; Flyger H; Nordestgaard BG; Benítez J; Milne RL; Ignacio Arias J; Zamora MP; Brenner H; Müller H; Arndt V; Rahman N; Turnbull C; Seal S; Renwick A; Brauch H; Justenhoven C; Brüning T; ; Chang-Claude J; Hein R; Wang-Gohrke S; Dörk T; Schürmann P; Bremer M; Hillemanns P; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Bogdanova N; Antonenkova N; Rogov YI; Karstens JH; Bermisheva M; Prokofieva D; Gantcev SH; Khusnutdinova E; Lindblom A; Margolin S; Chenevix-Trench G; Beesley J; Chen X; ; Mannermaa A; Kosma VM; Soini Y; Kataja V; Lambrechts D; Yesilyurt BT; Chrisiaens MR; Peeters S; Radice P; Peterlongo P; Manoukian S; Barile M; Couch F; Lee AM; Diasio R; Wang X; Giles GG; Severi G; Baglietto L; Maclean C; Offit K; Robson M; Joseph V; Gaudet M; John EM; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Andrulis I; Knight JA; Mulligan AM; O'Malley FP; Brinton LA; Sherman ME; Lissowska J; Chanock SJ; Hooning M; Martens JW; van den Ouweland AM; Collée JM; Hall P; Czene K; Cox A; Brock IW; Reed MW; Cross SS; Pharoah P; Dunning AM; Kang D; Yoo KY; Noh DY; Ahn SH; Jakubowska A; Lubinski J; Jaworska K; Durda K; Sangrajrang S; Gaborieau V; Brennan P; McKay J; Shen CY; Ding SL; Hsu HM; Yu JC; Anton-Culver H; Ziogas A; Ashworth A; Swerdlow A; Jones M; Orr N; Trentham-Dietz A; Egan K; Newcomb P; Titus-Ernstoff L; Easton D; Spurdle AB
Hum Mol Genet; 2011 Dec; 20(23):4693-706. PubMed ID: 21852249
[TBL] [Abstract][Full Text] [Related]
25. Relationship between five GWAS-identified single nucleotide polymorphisms and female breast cancer in the Chinese Han population.
He Y; Liu H; Chen Q; Sun X; Liu C; Shao Y
Tumour Biol; 2016 Jul; 37(7):9739-44. PubMed ID: 26803517
[TBL] [Abstract][Full Text] [Related]
26. A study on genetic variants of Fibroblast growth factor receptor 2 (FGFR2) and the risk of breast cancer from North India.
Siddiqui S; Chattopadhyay S; Akhtar MS; Najm MZ; Deo SV; Shukla NK; Husain SA
PLoS One; 2014; 9(10):e110426. PubMed ID: 25333473
[TBL] [Abstract][Full Text] [Related]
27. Comparison of genetic variation of breast cancer susceptibility genes in Chinese and German populations.
Barzan D; Veldwijk MR; Herskind C; Li Y; Zhang B; Sperk E; Du WD; Zhang XJ; Wenz F
Eur J Hum Genet; 2013 Nov; 21(11):1286-92. PubMed ID: 23486537
[TBL] [Abstract][Full Text] [Related]
28. Low-risk variants FGFR2, TNRC9 and LSP1 in German familial breast cancer patients.
Hemminki K; Müller-Myhsok B; Lichtner P; Engel C; Chen B; Burwinkel B; Försti A; Sutter C; Wappenschmidt B; Hellebrand H; Illig T; Arnold N; Niederacher D; Dworniczak B; Deissler H; Kast K; Gadzicki D; Meitinger T; Wichmann HE; Kiechle M; Bartram CR; Schmutzler RK; Meindl A
Int J Cancer; 2010 Jun; 126(12):2858-62. PubMed ID: 19856316
[TBL] [Abstract][Full Text] [Related]
29. Genetic polymorphism of fibroblast growth factor receptor 2 and trinucleotide repeat-containing 9 influence the susceptibility to HCV-induced hepatocellular carcinoma.
Al-Khaykanee AM; Abdel-Rahman AA; Essa A; Gadallah AA; Ali BH; Al-Aqar AA; Badr EAE; Shehab-Eldeen S
Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101636. PubMed ID: 33740609
[TBL] [Abstract][Full Text] [Related]
30. Two polymorphisms, rs2046210 and rs3803662, are associated with breast cancer risk in a Vietnamese case-control cohort.
Thanh NTN; Lan NTT; Phat PT; Giang NDT; Hue NT
Genes Genet Syst; 2018 Oct; 93(3):101-109. PubMed ID: 30078824
[TBL] [Abstract][Full Text] [Related]
31. Association of single nucleotide polymorphisms in FGF-RAS/MAP signalling cascade with breast cancer susceptibility.
Dankova Z; Zubor P; Grendar M; Kapinova A; Zelinova K; Jagelkova M; Gondova A; Dokus K; Kalman M; Lasabova Z; Danko J
Gen Physiol Biophys; 2017 Dec; 36(5):565-572. PubMed ID: 29372690
[TBL] [Abstract][Full Text] [Related]
32. Associations of polymorphisms in the genes of FGFR2, FGF1, and RBFOX2 with breast cancer risk by estrogen/progesterone receptor status.
Cen YL; Qi ML; Li HG; Su Y; Chen LJ; Lin Y; Chen WQ; Xie XM; Tang LY; Ren ZF
Mol Carcinog; 2013 Nov; 52 Suppl 1():E52-9. PubMed ID: 23143756
[TBL] [Abstract][Full Text] [Related]
33. Heterogeneity of Breast Cancer Associations with Common Genetic Variants in FGFR2 according to the Intrinsic Subtypes in Southern Han Chinese Women.
Liang H; Yang X; Chen L; Li H; Zhu A; Sun M; Wang H; Li M
Biomed Res Int; 2015; 2015():626948. PubMed ID: 26421298
[TBL] [Abstract][Full Text] [Related]
34. Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium.
Broeks A; Schmidt MK; Sherman ME; Couch FJ; Hopper JL; Dite GS; Apicella C; Smith LD; Hammet F; Southey MC; Van 't Veer LJ; de Groot R; Smit VT; Fasching PA; Beckmann MW; Jud S; Ekici AB; Hartmann A; Hein A; Schulz-Wendtland R; Burwinkel B; Marme F; Schneeweiss A; Sinn HP; Sohn C; Tchatchou S; Bojesen SE; Nordestgaard BG; Flyger H; Ørsted DD; Kaur-Knudsen D; Milne RL; Pérez JI; Zamora P; Rodríguez PM; Benítez J; Brauch H; Justenhoven C; Ko YD; ; Hamann U; Fischer HP; Brüning T; Pesch B; Chang-Claude J; Wang-Gohrke S; Bremer M; Karstens JH; Hillemanns P; Dörk T; Nevanlinna HA; Heikkinen T; Heikkilä P; Blomqvist C; Aittomäki K; Aaltonen K; Lindblom A; Margolin S; Mannermaa A; Kosma VM; Kauppinen JM; Kataja V; Auvinen P; Eskelinen M; Soini Y; Chenevix-Trench G; Spurdle AB; Beesley J; Chen X; Holland H; ; ; Lambrechts D; Claes B; Vandorpe T; Neven P; Wildiers H; Flesch-Janys D; Hein R; Löning T; Kosel M; Fredericksen ZS; Wang X; Giles GG; Baglietto L; Severi G; McLean C; Haiman CA; Henderson BE; Le Marchand L; Kolonel LN; Alnæs GG; Kristensen V; Børresen-Dale AL; Hunter DJ; Hankinson SE; Andrulis IL; Mulligan AM; O'Malley FP; Devilee P; Huijts PE; Tollenaar RA; Van Asperen CJ; Seynaeve CS; Chanock SJ; Lissowska J; Brinton L; Peplonska B; Figueroa J; Yang XR; Hooning MJ; Hollestelle A; Oldenburg RA; Jager A; Kriege M; Ozturk B; van Leenders GJ; Hall P; Czene K; Humphreys K; Liu J; Cox A; Connley D; Cramp HE; Cross SS; Balasubramanian SP; Reed MW; Dunning AM; Easton DF; Humphreys MK; Caldas C; Blows F; Driver K; Provenzano E; Lubinski J; Jakubowska A; Huzarski T; Byrski T; Cybulski C; Gorski B; Gronwald J; Brennan P; Sangrajrang S; Gaborieau V; Shen CY; Hsiung CN; Yu JC; Chen ST; Hsu GC; Hou MF; Huang CS; Anton-Culver H; Ziogas A; Pharoah PD; Garcia-Closas M
Hum Mol Genet; 2011 Aug; 20(16):3289-303. PubMed ID: 21596841
[TBL] [Abstract][Full Text] [Related]
35. The influence of genetic variation in 30 selected genes on the clinical characteristics of early onset breast cancer.
Tapper W; Hammond V; Gerty S; Ennis S; Simmonds P; Collins A; ; Eccles D
Breast Cancer Res; 2008; 10(6):R108. PubMed ID: 19094228
[TBL] [Abstract][Full Text] [Related]
36. Predictive accuracy of the breast cancer genetic risk model based on eight common genetic variants: The BACkSIDE study.
Danková Z; Žúbor P; Grendár M; Zelinová K; Jagelková M; Stastny I; Kapinová A; Vargová D; Kasajová P; Dvorská D; Kalman M; Danko J; Lasabová Z
J Biotechnol; 2019 Jun; 299():1-7. PubMed ID: 31002855
[TBL] [Abstract][Full Text] [Related]
37. Association of low-penetrance alleles with male breast cancer risk and clinicopathological characteristics: results from a multicenter study in Italy.
Ottini L; Silvestri V; Saieva C; Rizzolo P; Zanna I; Falchetti M; Masala G; Navazio AS; Graziano V; Bianchi S; Manoukian S; Barile M; Peterlongo P; D'Amico C; Varesco L; Tommasi S; Russo A; Giannini G; Cortesi L; Viel A; Montagna M; Radice P; Palli D
Breast Cancer Res Treat; 2013 Apr; 138(3):861-8. PubMed ID: 23468243
[TBL] [Abstract][Full Text] [Related]
38. Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) Study.
Teraoka SN; Bernstein JL; Reiner AS; Haile RW; Bernstein L; Lynch CF; Malone KE; Stovall M; Capanu M; Liang X; Smith SA; Mychaleckyj J; Hou X; Mellemkjaer L; Boice JD; Siniard A; Duggan D; Thomas DC; ; Concannon P
Breast Cancer Res; 2011; 13(6):R114. PubMed ID: 22087758
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of breast cancer susceptibility loci in Chinese women.
Long J; Shu XO; Cai Q; Gao YT; Zheng Y; Li G; Li C; Gu K; Wen W; Xiang YB; Lu W; Zheng W
Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2357-65. PubMed ID: 20699374
[TBL] [Abstract][Full Text] [Related]
40. Association of polymorphisms in intron 2 of FGFR2 and breast cancer risk in Сhinese women.
Pan Z; Bao Y; Zheng X; Cao W; Cheng W; Xu X
Tsitol Genet; 2016; 50(5):59-64. PubMed ID: 30480917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
